These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32611307)

  • 1. Patient-reported and doctor-reported symptoms when faecal immunochemical tests are requested in primary care in the diagnosis of colorectal cancer and inflammatory bowel disease: a prospective study.
    Högberg C; Karling P; Rutegård J; Lilja M
    BMC Fam Pract; 2020 Jul; 21(1):129. PubMed ID: 32611307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative faecal immunochemical tests (FITs) for diagnosing colorectal cancer in patients with histories of rectal bleeding in primary care: a cohort study.
    Högberg C; Gunnarsson U; Cronberg O; Thulesius H; Lilja M; Jansson S
    Int J Colorectal Dis; 2020 Nov; 35(11):2035-2040. PubMed ID: 32602056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
    Högberg C; Karling P; Rutegård J; Lilja M
    Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
    Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
    Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between a sign of rectal bleeding and the results of an immunochemical occult blood test, and colorectal cancer.
    Nakama H; Zhang B; Abdul Fattah AS; Kamijo N; Fukazawa K
    Eur J Cancer Prev; 2000 Oct; 9(5):325-8. PubMed ID: 11075885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of faecal haemoglobin with a faecal immunochemical test can assist in defining which patients attending primary care with rectal bleeding require urgent referral.
    Digby J; Strachan JA; McCann R; Steele RJ; Fraser CG; Mowat C
    Ann Clin Biochem; 2020 Jul; 57(4):325-327. PubMed ID: 32482080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of primary-care led, faecal immunochemical test-based, triage of new-onset colorectal symptoms on time to diagnosis of colorectal cancer-An observational study.
    Atwal GK; Digby J; Nobes J; Strachan J; Mowat C
    Colorectal Dis; 2024 Aug; 26(8):1544-1550. PubMed ID: 38949100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
    Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy.
    Tsapournas G; Hellström PM; Cao Y; Olsson LI
    Scand J Gastroenterol; 2020 Feb; 55(2):184-192. PubMed ID: 31906738
    [No Abstract]   [Full Text] [Related]  

  • 10. Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer.
    Chapman C; Bunce J; Oliver S; Ng O; Tangri A; Rogers R; Logan RF; Humes DJ; Banerjea A
    BJS Open; 2019 Jun; 3(3):395-402. PubMed ID: 31183456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluation.
    Bailey JA; Weller J; Chapman CJ; Ford A; Hardy K; Oliver S; Morling JR; Simpson JA; Humes DJ; Banerjea A
    BJS Open; 2021 Mar; 5(2):. PubMed ID: 33693553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of patients with non-metastatic colorectal cancer in primary care: a case-control study.
    Ewing M; Naredi P; Zhang C; Månsson J
    Br J Gen Pract; 2016 Dec; 66(653):e880-e886. PubMed ID: 27821670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of ten gastrointestinal and other medical conditions with positivity to faecal occult blood testing in routine screening: a large prospective study of women in England.
    He E; Alison R; Blanks R; Pirie K; Reeves G; Ward RL; Steele R; Patnick J; Canfell K; Beral V; Green J
    Int J Epidemiol; 2019 Apr; 48(2):549-558. PubMed ID: 30668711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests.
    Nicholson BD; James T; Paddon M; Justice S; Oke JL; East JE; Shine B
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1031-1041. PubMed ID: 32677733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients.
    Cubiella J; Vega P; Salve M; Díaz-Ondina M; Alves MT; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Clofent J; Ferrandez Á; Torrealba L; Piñol V; Rodríguez-Alcalde D; Hernández V; Fernández-Seara J;
    BMC Med; 2016 Aug; 14(1):128. PubMed ID: 27580745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer prevalence in faecal immunochemical test non-returners: potential for health inequality in symptomatic referral pathways.
    Gerrard AD; Coxon J; Maeda Y; Theodoratou E; Dunlop MG; Din FVN
    BJS Open; 2024 Sep; 8(5):. PubMed ID: 39404039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal immunochemical tests (FIT) in the assessment of patients presenting with lower bowel symptoms: Concepts and challenges.
    Fraser CG
    Surgeon; 2018 Oct; 16(5):302-308. PubMed ID: 29548552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal immunochemical tests for occult blood testing should not be used outside of bowel screening: an audit of a large general practice.
    Byun UH; Anderson N; Upton A; Frankish P
    J Prim Health Care; 2019 Sep; 11(3):259-264. PubMed ID: 32171379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study.
    Turvill J; Aghahoseini A; Sivarajasingham N; Abbas K; Choudhry M; Polyzois K; Lasithiotakis K; Volanaki D; Kim B; Langlands F; Andrew H; Roos J; Mellen S; Turnock D; Jones A
    Br J Gen Pract; 2016 Jul; 66(648):e499-506. PubMed ID: 27266863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining faecal immunochemical testing with blood test results for colorectal cancer risk stratification: a consecutive cohort of 16,604 patients presenting to primary care.
    Withrow DR; Shine B; Oke J; Tamm A; James T; Morris E; Davies J; Harris S; East JE; Nicholson BD
    BMC Med; 2022 Mar; 20(1):116. PubMed ID: 35287679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.